Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
Giovanni Di Zenzo(Istituto Dermopatico dell'Immacolata), Antonio Lanzavecchia(Vir Biotechnology (Switzerland)), Giovanna Zambruno(Bambino Gesù Children's Hospital), Biagio Didona(Istituto Dermopatico dell'Immacolata), Rüdiger Eming(Philipps University of Marburg), Valentina Calabresi(Istituto Dermopatico dell'Immacolata), Michael Hertl(Universitätsklinikum Gießen und Marburg), Jerry W. Sloostra(Pepscan (Netherlands)), Takashi Hashimoto(Osaka Metropolitan University), Federica Sallusto(Unknown), Giulia Di Lullo(Vita-Salute San Raffaele University), Giuseppe Cianchini(Istituto Dermopatico dell'Immacolata), Masayuki Amagai(Keio University), Fabrizia Vanzetta(Vir Biotechnology (Switzerland)), Davide Corti(Vir Biotechnology (Switzerland)), Bungo Ohyama(Kurume University), Anna Sinistro(University of Rome Tor Vergata)
Cited by 175
Related Papers
Inflammation-free, gas-permeable, lightweight, stretchable on-skin electronics with nanomeshes
|Nature Nanotechnology|2017|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
|Journal of the American Academy of Dermatology|2014|933
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
|Journal of the American Academy of Dermatology|2008|933